Shell Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50K Sell
2,934
-628
-18% -$10.7K ﹤0.01% 1145
2025
Q1
$227K Sell
3,562
-146
-4% -$9.3K 0.01% 740
2024
Q4
$451K Sell
3,708
-6
-0.2% -$730 0.02% 528
2024
Q3
$464K Buy
+3,714
New +$464K 0.02% 518
2024
Q1
$591K Sell
3,740
-375
-9% -$59.3K 0.03% 418
2023
Q4
$397K Sell
4,115
-1,232
-23% -$119K 0.02% 601
2023
Q3
$648K Sell
5,347
-93
-2% -$11.3K 0.03% 463
2023
Q2
$623K Buy
5,440
+1,090
+25% +$125K 0.02% 504
2023
Q1
$600K Sell
4,350
-15
-0.3% -$2.07K 0.02% 495
2022
Q4
$566K Sell
4,365
-880
-17% -$114K 0.02% 490
2022
Q3
$580K Sell
5,245
-1,371
-21% -$152K 0.02% 502
2022
Q2
$496K Buy
6,616
+1,135
+21% +$85.1K 0.01% 724
2022
Q1
$428K Sell
5,481
-812
-13% -$63.4K 0.01% 880
2021
Q4
$567K Buy
6,293
+26
+0.4% +$2.34K 0.01% 844
2021
Q3
$580K Sell
6,267
-270
-4% -$25K 0.01% 801
2021
Q2
$508K Buy
6,537
+2,860
+78% +$222K 0.01% 911
2021
Q1
$274K Sell
3,677
-4,099
-53% -$305K 0.01% 1057
2020
Q4
$1.33M Buy
7,776
+163
+2% +$27.8K 0.03% 450
2020
Q3
$1.07M Sell
7,613
-1,473
-16% -$207K 0.02% 439
2020
Q2
$1.46M Buy
9,086
+1,031
+13% +$165K 0.04% 364
2020
Q1
$788K Sell
8,055
-1,697
-17% -$166K 0.02% 493
2019
Q4
$1.26M Buy
9,752
+1,842
+23% +$238K 0.03% 465
2019
Q3
$596K Sell
7,910
-4,622
-37% -$348K 0.01% 804
2019
Q2
$1.9M Sell
12,532
-151
-1% -$22.9K 0.04% 361
2019
Q1
$1.51M Buy
12,683
+5,959
+89% +$710K 0.03% 410
2018
Q4
$734K Sell
6,724
-600
-8% -$65.5K 0.02% 662
2018
Q3
$1.18M Hold
7,324
0.02% 574
2018
Q2
$968K Sell
7,324
-391
-5% -$51.7K 0.02% 698
2018
Q1
$572K Hold
7,715
0.01% 876
2017
Q4
$429K Buy
+7,715
New +$429K 0.01% 949